ALKERMES | ALKS - Активы





Активы Изменить Дата
AbbVie USD 147.68B 12.57B 2026-09
Acadia Pharmaceuticals USD 1.79B 51.25M 2026-09
ALKERMES USD 4.44B 42.4M 2026-09
Amgen USD 96.05B 409M 2026-09
Biogen USD 32.05B 32.5M 2026-09
BioMarin Pharmaceutical USD 11.57B 154.21M 2026-09
Bristol-Myers Squibb USD 88.77B 1.14B 2026-09
Coherus Biosciences USD 191.18M 74.84M 2026-06
Eli Lilly USD 148.07B 5.79B 2026-09
Gilead Sciences USD 51.41B 2.05B 2026-09
Heron Therapeutics USD 252.26M 6.05M 2026-06
Ionis Pharmaceuticals USD 2.99B 455.5M 2026-06
J&J USD 197.42B 3.64B 2026-09
Malin Corporation EUR 198.5M 70.1M 2024-12
Merck USD 132.77B 2.97B 2026-09
Minerva Neurosciences USD 97.97M 69.88M 2025-12
Nektar Therapeutics USD 763.27M 482.86M 2026-03
Neurocrine Biosciences USD 5.63B 268.3M 2026-09
Otsuka Holdings JPY 4.32T 72.62B 2026-09
Ovoca Bio EUR 2.07M 414K 2025-12
Pfizer USD 204.54B 3.41B 2026-09
Regeneron Pharmaceuticals USD 44.41B 2.67B 2026-09
Vertex Pharmaceuticals USD 32.74B 5.31B 2026-09